Cytokines as Prognostic Biomarkers of Epithelial Ovarian Cancer (EOC): A Systematic Review and Meta-Analysis (original) (raw)

Asian Pacific Journal of Cancer Prevention

22 (2), 315-323 ovarian cancer (EOC) include surgery and chemotherapy (Ledermann et al., 2013). However, the prognosis of patients who undergo those treatments are poor. The 5-year cause-specific survival of EOC for all stages is 47% (Torre et al., 2018). There are many factors affecting survival in EOC, for instance, cancer stage, age at diagnosis, histopathological type, pathological grade, surgical status, residual disease, performance status, and biological factors such as proteins and gene expressions (Onal et al., 2017). Prognostic factors may help clinicians in deciding on types of surgery and adjuvant therapies according to individual risks. The role of immunology in ovarian cancer has been

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact